- Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in…
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each…
Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes…
Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for…
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext…
Conduit Pharmaceuticals strengthens its Board of Directors with the addition of Simon Fry, a seasoned investment banking executive with over…
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- GQR Life Sciences, a leader in total talent solutions for the biopharma industry, is…
Pharma and health care industries take deliberate steps, not leaps, toward AI innovation and digital transformation CARY, N.C., Nov. 19,…
List recognizes groundbreaking advancements redefining the way we work and live. CAMBRIDGE, Mass., Nov. 19, 2024 /PRNewswire/ -- Epicore Biosystems (Epicore),…
Choosing Canada as its first market outside of Europe, Aktiia's clinically validated 'cuffless' blood monitoring bracelet is now available as the…